Gouvernance AVEO Pharmaceuticals, Inc. Börse Stuttgart

VPA

US0535881090

Produits pharmaceutiques

Temps Différé Börse Stuttgart 16:33:53 05/10/2021			Varia. 5j.	Varia. 1 janv.
5,280 ^EUR	-0,19%		-10,02%	+20,93%

22/07	Arcus Biosciences annonce un accord de fourniture clinique avec Aveo Oncology pour évaluer le casdatifan en association avec le tivozanib dans le cancer du rein avancé	CI
30/06	AVEO Pharmaceuticals, Inc. annonce des changements au sein de sa direction	CI

Comité Exécutif: AVEO Pharmaceuticals, Inc.

Dirigeant

Fonctions occupéesDepuis

Michael Ferraresso

Chief Executive Officer	01/07/2026
President	01/07/2026

Deb Wall

Human Resources Officer

01/07/2024

David Crist

Sales & Marketing

19/10/2020

Danielle Holland

General Counsel	-
Corporate Secretary	-

Anisha Wharton

General Counsel

01/01/2021

Edgar Braendle

Chief Tech/Sci/R&D Officer

01/03/2024

Jinchul Jeong

Director of Finance/CFO

Reetu Dandora

General Counsel

Bob Fedak

Chief Tech/Sci/R&D Officer

01/07/2023

Karam Hijji

General Counsel

01/01/2025

Greg Oehrtman

Chief Tech/Sci/R&D Officer

01/08/2022

Composition du Conseil d'Administration: AVEO Pharmaceuticals, Inc.

Administrateur

ComitésDepuis

Michael Bailey

60 ans

Governance Committee Chair

01/05/2022

Heuisul Park

Director/Board Member

Jeewoong Son

Director/Board Member

Michael Ferraresso

Director/Board Member

01/07/2026

Jinchul Jeong

Director/Board Member

Anciens Dirigeants et Administrateurs: AVEO Pharmaceuticals, Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Jebediah Ledell

Chief Operating Officer

01/12/2021

01/12/2024

Catherine DeRose

Human Resources Officer

01/09/2020

01/03/2023

Erick Lucera

Director of Finance/CFO

06/01/2020

01/02/2023

Jaywin Lee

Director/Board Member

19/01/2023

Kevin J. Cullen

Director/Board Member	15/04/2021	19/01/2023
Independent Dir/Board Member	15/04/2021	19/01/2023

Gregory Mayes

Director/Board Member	27/02/2019	19/01/2023
Independent Dir/Board Member	27/02/2019	19/01/2023

Scarlett Spring

Director/Board Member	18/11/2019	19/01/2023
Independent Dir/Board Member	18/11/2019	19/01/2023

Corinne Epperly

Director/Board Member	06/01/2021	19/01/2023
Independent Dir/Board Member	06/01/2021	19/01/2023

Ken Bate

Director/Board Member	01/12/2007	-
Chairman	-	19/01/2023
Independent Dir/Board Member	01/12/2007	19/01/2023

Anthony Evnin

Director/Board Member	01/03/2002	19/01/2023
Independent Dir/Board Member	01/03/2002	19/01/2023

Lisa M. Bruneau

Comptroller/Controller/Auditor	01/01/2016	01/01/2023
Treasurer	01/01/2016	01/01/2023

Valerie L. Legagneur

Corporate Officer/Principal

01/05/2022

Michael N. Needle

Chief Tech/Sci/R&D Officer

10/01/2015

19/11/2021

Robert C. Young

Director/Board Member	01/07/2009	09/06/2021
Independent Dir/Board Member	01/07/2009	09/06/2021

Raju S. Kucherlapati

Director/Board Member	19/10/2002	01/02/2021
Independent Dir/Board Member	06/04/2011	01/02/2021

Karuna Rubin

General Counsel	01/07/2016	21/01/2021
Corporate Secretary	01/07/2016	21/01/2021

Nikhil Mehta

General Counsel

20/11/2017

08/10/2019

John Johnson

Director/Board Member

01/02/2018

27/02/2019

Keith S. Ehrlich

Comptroller/Controller/Auditor	-	01/06/2017
Director of Finance/CFO	19/04/2015	01/06/2017

Henri A. Termeer

Director/Board Member	11/04/2011	23/05/2017
Chairman	17/07/2012	07/01/2015
Independent Dir/Board Member	11/04/2011	23/05/2017

Tuan Ha-Ngoc

Director/Board Member	05/04/2011	06/01/2015
Chief Executive Officer	01/06/2002	07/01/2015
Chairman	06/01/2015	06/11/2015
Director of Finance/CFO	01/06/2002	07/01/2015
President	01/06/2002	07/01/2015

Joseph Vittiglio

General Counsel	05/04/2011	19/03/2015
Corporate Secretary	01/01/2007	19/03/2015

Matthew D. Dallas

Comptroller/Controller/Auditor	01/07/2014	06/02/2015
Treasurer	01/07/2014	06/02/2015
Director of Finance/CFO	01/06/2017	26/09/2019

Jeno Gyuris

Chief Tech/Sci/R&D Officer	05/04/2011	15/01/2015
Corporate Officer/Principal	01/01/2003	05/04/2011

Robert Epstein

Director/Board Member	31/12/2012	19/06/2014
Independent Dir/Board Member	31/12/2012	19/06/2014

William J. Slichenmyer

Chief Tech/Sci/R&D Officer

18/09/2009

30/04/2014

David B. Johnston

Director of Finance/CFO

01/10/2007

30/12/2013

Kenneth Weg

Director/Board Member	01/01/2002	01/08/2013
Founder	19/10/2001	01/08/2013
Independent Dir/Board Member	19/10/2001	01/08/2013

Elan Ezickson

Chief Operating Officer	07/02/2012	31/07/2013
Corporate Officer/Principal	01/04/2003	07/02/2012

Shubh Goel

Sales & Marketing

01/01/2011

01/01/2013

Anna Berkenblit

Chief Tech/Sci/R&D Officer

01/01/2011

01/01/2013

Suzanne Fleming

Director of Finance/CFO	01/11/2005	05/04/2011
Corporate Officer/Principal	05/04/2011	01/01/2013

Ronald DePinho

Director/Board Member	01/01/2002	31/12/2012
Founder	19/10/2001	31/12/2012

Nicholas Galakatos

Director/Board Member	01/03/2002	30/05/2012
Independent Dir/Board Member	06/04/2011	30/05/2012

Emile Farhan

Chief Tech/Sci/R&D Officer	01/04/2012	-
Corporate Officer/Principal	01/04/2012	-

Russell C. Hirsch

Director/Board Member	13/04/2011	01/06/2011
Independent Dir/Board Member	13/04/2011	01/06/2011

Douglas Cole

Director/Board Member	19/10/2001	01/06/2011
Independent Dir/Board Member	19/10/2001	01/06/2011

Pankaj Bhargava

Chief Tech/Sci/R&D Officer

01/11/2006

Albert Dauray

Chief Tech/Sci/R&D Officer

01/01/2011

Carole Varanelli

Corporate Officer/Principal

01/01/2011

Mary Ellen Jones

Human Resources Officer

01/01/2011

Donna M. Radzik

Chief Operating Officer	14/09/2010	06/04/2011
Chief Tech/Sci/R&D Officer	14/09/2010	06/04/2011
Corporate Officer/Principal	06/04/2011	-

Robert Higgins

Director/Board Member

15/12/2009

John Ryan

Chief Tech/Sci/R&D Officer

01/04/2006

01/01/2009

Margaret Taleff

General Counsel

05/04/2011

A. Grant Heidrich

Director/Board Member

01/01/2002

01/04/2007

Steven C. Clark

Chief Tech/Sci/R&D Officer

01/01/2001

01/01/2007

Murray O. Robinson

Corporate Officer/Principal

01/01/2003

Lynda Chin

Founder

19/10/2001

Michael J. Buehler-Garcia

Director of Finance/CFO

M. Isabel Chiu

Corporate Officer/Principal

Stefanie Solomon

Compliance Officer

Matthew Coulter

Chief Tech/Sci/R&D Officer

Charlene Stern

Corporate Officer/Principal

H. Robert Horvitz

Corporate Officer/Principal

Muzammil Mansuri

Director/Board Member

Todd Foley

Corporate Officer/Principal

Jasbir Seehra

Corporate Officer/Principal

Tomasz H. Zastawny

Corporate Officer/Principal

Monique Allaire

Investor Relations Contact	06/04/2011	-
Public Communications Contact	24/08/2011	-

Tiffany Crowell

Corporate Officer/Principal

Peter J. Courossi

Director of Finance/CFO

Michael Boretti

Corporate Officer/Principal

Robert Kloppenburg

Investor Relations Contact

Darlene Noci

General Counsel

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	11
Femme	5

Dont comité exécutif

Homme	7
Femme	4

Dont Administrateurs

Homme	5
Femme	0

AVEO Pharmaceuticals, Inc. est une société biopharmaceutique axée sur l'oncologie. La société se concentre sur la fourniture de médicaments pour les patients atteints de cancer. Le produit commercial de la société comprend FOTIVDA (tivozanib), qui est un inhibiteur oral de la tyrosine kinase (TKI) et du récepteur du facteur de croissance endothélial vasculaire (VEGFR). La société commercialise FOTIVDA (tivozanib) aux États-Unis pour le traitement des patients adultes atteints de carcinome rénal récidivant ou réfractaire (RCC) après deux ou plusieurs traitements systémiques antérieurs. Elle développe également FOTIVDA dans des combinaisons immuno-oncologiques pour le traitement du RCC réfractaire et d'autres indications et possède plusieurs autres programmes expérimentaux en développement clinique. Le pipeline de produits candidats de la société comprend ficlatuzumab, AV-380, AV-203 et AV-353. Son ficlatuzumab est un puissant anticorps monoclonal humanisé de type immunoglobuline G1 (IgG1) qui cible le facteur de croissance des hépatocytes (HGF).

Employés

Secteur

Produits pharmaceutiques

Plus d'informations sur la société